DK170989A - Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin - Google Patents

Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin

Info

Publication number
DK170989A
DK170989A DK170989A DK170989A DK170989A DK 170989 A DK170989 A DK 170989A DK 170989 A DK170989 A DK 170989A DK 170989 A DK170989 A DK 170989A DK 170989 A DK170989 A DK 170989A
Authority
DK
Denmark
Prior art keywords
receptor antagonist
protamin
thromboxan
prevent
side effects
Prior art date
Application number
DK170989A
Other languages
English (en)
Other versions
DK170989D0 (da
Inventor
Martin Lawrence Ogletree
William Anthony Schumacher
Gary James Grover
Lawrence Tim Friedhoff
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK170989D0 publication Critical patent/DK170989D0/da
Publication of DK170989A publication Critical patent/DK170989A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK170989A 1988-04-11 1989-04-10 Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin DK170989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/179,694 US5066480A (en) 1988-04-11 1988-04-11 Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist

Publications (2)

Publication Number Publication Date
DK170989D0 DK170989D0 (da) 1989-04-10
DK170989A true DK170989A (da) 1989-10-12

Family

ID=22657593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK170989A DK170989A (da) 1988-04-11 1989-04-10 Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin

Country Status (12)

Country Link
US (1) US5066480A (da)
EP (1) EP0337697B1 (da)
JP (1) JPH0296537A (da)
AT (1) ATE92323T1 (da)
AU (1) AU624370B2 (da)
CA (1) CA1336953C (da)
DE (1) DE68907976T2 (da)
DK (1) DK170989A (da)
HU (1) HU206261B (da)
IE (1) IE63735B1 (da)
NZ (1) NZ228491A (da)
ZA (1) ZA892412B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07507769A (ja) * 1992-03-20 1995-08-31 コアー・セラピュティックス・インコーポレーテッド Ｘ因子のグリコシル化媒介による阻害
US7356737B2 (en) * 2004-10-29 2008-04-08 International Business Machines Corporation System, method and storage medium for testing a memory module
ES2848348T3 (es) * 2014-05-16 2021-08-06 Cumberland Pharmaceuticals Inc Composiciones y métodos de tratamiento con ifetroban de la fibrosis cardíaca
KR20220137141A (ko) 2015-06-30 2022-10-11 큠버랜드 파마슈티컬즈 인코포레이티드 Ａｅｒｄ/천식에서 트롬복산 수용체 길항제
JP7003062B2 (ja) 2016-05-11 2022-01-20 カンバーランド ファーマシューティカルズ，インコーポレーテッド トロンボキサンａ２受容体拮抗薬により筋ジストロフィーを治療する組成物及び方法
AU2018375378A1 (en) 2017-11-29 2020-05-28 Vanderbilt University Methods of inhibiting tumor metastasis
US11494695B2 (en) 2019-09-27 2022-11-08 Google Llc Training neural networks to generate structured embeddings

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
ZA827529B (en) * 1981-11-09 1983-09-28 Squibb & Sons Inc 7-oxabicycloheptane and 7-oxabicycloheptene compounds
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
HU206261B (en) 1992-10-28
DE68907976T2 (de) 1994-03-31
EP0337697A3 (en) 1990-08-16
IE891061L (en) 1989-10-11
AU3269189A (en) 1989-10-12
AU624370B2 (en) 1992-06-11
CA1336953C (en) 1995-09-12
EP0337697A2 (en) 1989-10-18
EP0337697B1 (en) 1993-08-04
HUT52372A (en) 1990-07-28
US5066480A (en) 1991-11-19
DE68907976D1 (de) 1993-09-09
JPH0296537A (ja) 1990-04-09
NZ228491A (en) 1997-03-24
ZA892412B (en) 1990-01-31
IE63735B1 (en) 1995-06-14
DK170989D0 (da) 1989-04-10
ATE92323T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
DK170989A (da) Anvendelse af thromboxan a2 receptor-antagonist til hindring eller mindskning af uoenskede bivirkninger af protamin
ES2055114T3 (es) Isomerizacion de hidrocarburos fluorados saturados.
DK119387A (da) Stejltransportoer, isaer til losning af skibe
DE68900668D1 (de) Rotorkopf mit einer elastischen, innengedaempften, zwischenblattrueckholung.
DE68922235D1 (de) Durch Acetylen, Cyan oder Allen substituierte Aristeromycin- oder Adenosin-Derivate.
DE69030909D1 (de) Verwendung von modifiziertem Heparin Kofaktor II
KR830006304A (ko) 디옥사이드 화합물의 제조방법
DK0624196T3 (da) Polypeptider med fibronectinbindingssteder som modulator for matrixopbygning.
DE58901632D1 (de) Bauelement zur verkleidung der fassaden von bauwerken.
ATE46473T1 (de) Holzschutzmittel.
GB1483158A (en) Preparation of cyclododecatriene
DE3764986D1 (de) Monoazoverbindung mit einer faserreaktiven gruppe des vinylsulfon-typs, getragen von einem substituierten triazinbrueckenglied.
FR2414597A1 (fr) Modules autoporteurs destines a servir de toitures pour les edifices de petite et moyenne surfaces
EP0159035A3 (de) Verwendung von reaktiven Verdünnern für Epoxidharze, sowie Epoxidharzmasse
IT1218103B (it) Serratura-sbarra a mandata unica funzionante con cilindro tradizionale
FI895335A0 (fi) Foerfarande foer att stoppa en medelst en asynkronmotor driven horisontal trumma foersedd anordning i ett visst laege, och en tvaett- och/eller torkmaskin som tillaempar foerfarandet.
FR2566023B1 (fr) Plate-forme marine, notamment destinee a former une base de loisirs
GB1196460A (en) Improvements in Methods for the Production of Composite Girders
RU1581046C (ru) Органический сцинтилл тор
SE8202351L (sv) Farmaceutiskt preparat
SU672207A1 (ru) Полировальный состав дл оптических деталей
DE69301384D1 (de) Verwendung wasserlöslicher Dispergiermittel, hergestellt durch Sulfonieren von Inden oder Gemischen von Inden mit Aromaten
ATE58725T1 (de) Tetrahydroisochinolin-2-yl-derivate von carbonsaeuren als thromboxan a2-antagonisten.
Josey Element Design Guide, External Walls. III. Curtain Walls
JPS52101555A (en) Hydraulic elevator

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed
AHS Application shelved for other reasons than non-payment